Plasmatic is an adjective referred to all that concerns the plasma, ie the liquid part of the blood.
The different components of the plasma (proteins, ions, organic molecules, gases, etc.) can be isolated and dosed, obtaining the so-called plasma concentrations, ie the quantities of such solutes in a known volume of plasma (for example a deciliter or a liter) . During blood tests, the sample taken by the patient is subjected to centrifugation, in order to separate the cellular component (corpusculate) from the liquid component (plasma). The plasma concentrations of the various components are then determined in the latter. Therefore, although we are talking about blood tests, most of the tests are actually carried out on plasma or serum.
The following tables show the average concentrations of the various plasma components; the data can vary in a more or less important way from laboratory to laboratory and based on the bibliographic sources consulted.
| Test | Lower normal limit | Upper limit of normal | Unit of measure |
| Total plasma cholesterol | 3.0 - 3.6 | 5.0 - 6.5 | mmol / L |
| 120 - 140 | 200 - 250 | mg / dL | |
| HDL plasma cholesterol in women | 1.0 - 1.2 - 1.3 | 2.2 | mmol / L |
| 40 - 50 | 86 | mg / dL | |
| HDL plasma cholesterol in the male | 0.9 | 2.0 | mmol / L |
| 35 | 80 | mg / dL | |
| LDL plasma cholesterol | 2.0 - 2.4 | 3.0 - 3.4 | mmol / L |
| 80 - 94 | 120 - 130 | mg / dL | |
| Plasma glucose (blood glucose) | 3.8 - 4.0 | 6.0 - 6.1 | mmol / L |
| 65 - 70 - 72 | 100 - 110 | mg / dL | |
| Plasma osmolality | 275 - 280 - 281 | 295 - 296 - 297 | mOsm / kg |
| Plasma osmolarity | Slightly lower than osmolality | mOsm / l | |
| plasma pH | Arterial | 7.34 - 7.35 | 7.44 - 7.45 |
| Venous | 7:31 | 7:41 | |
| Plasma urea | 1.2 - 3.0 | 3.0 - 7.0 | mmol / L |
| 7 | 18 - 21 | mg / dL | |
| Plasma sodium (Na) | 135 - 137 | 145 - 147 | mmol / L or mEq / L |
| 31 - 32 | 33 - 34 | mg / dl | |
| Plasma potassium (K) | 3.5 - 3.6 | 5.0 - 5.1 | mmol / L or mEq / L |
| 14 | 20 | mg / dl | |
| Plasmatic chlorine (Cl) | 95 - 98 - 100 | 105 - 106 - 110 | mmol / L or mEq / L |
| 340 | 370 | mg / dl | |
| Plasma ionized calcium (Ca) | 1.03 - 1.10 | 1.23 - 1.30 | mmol / L |
| 4.1 - 4.4 | 4.9 - 5.2 | mg / dL | |
| Plasma ammonia | 10 - 20 | 35 - 65 | mmol / L |
| 17 - 34 | 60 - 110 | mg / dL | |
| Plasma copper | 70 | 150 | mg / dL |
| 11 | 24 | mmol / L | |
| Plasmatic ceruloplasmin | 15 | 60 | mg / dL |
| 1 | 4 | mmol / L | |
| Total plasma calcium | 2.1 - 2.2 | 2.5 - 2.6 - 2.8 | mmol / L |
| 8.4 - 8.5 | 10.2 - 10.5 | mg / dL | |
| Plasma phosphate (HPO42−) | 0.8 | 1.5 | mmol / L |
| Inorganic phosphorus (serum) | 1.0 | 1.5 | mmol / L |
| 3.0 | 4.5 | mg / dL | |
| Plasma zinc (Zn) | 60 - 72 | 110 - 130 | mg / dL |
| 9.2 - 11 | 17 - 20 | mmol / L | |
| Plasma magnesium | 1.5 - 1.7 | 2.0 - 2.3 | mEq / L or mg / dL |
| 0.6 - 0.7 | 0.82 - 0.95 | mmol / L | |
| Selenium (optimal range) | 120 | mg / L | |
| Plasma fibrinogen | 1.7 - 2.0 | 3.6 - 4.2 | g / L |
| Plasma antithrombin | 0.80 | 1.2 | kIU / L |
| Test | Sex | Age | Lower limit | Upper limit | Unit of measure | High | Therapeutic target |
| Plasma homocysteine | Female | 12-19 years | 3.3 | 7.2 | mmol / L | > 10.4 μmol / L or > 140 μg / dl | <6.3 μmol / L or <85 μg / dL |
| 45 | 100 | mg / dL | |||||
| > 60 years | 4.9 | 11.6 | mmol / L | ||||
| 66 | 160 | mg / dL | |||||
| Male | 12-19 years | 4.3 | 9.9 | mmol / L | > 11.4 μmol / L or > 150 μg / dL | ||
| 60 | 130 | mg / dL | |||||
| > 60 years | 5.9 | 15.3 | mmol / L | ||||
| 80 | 210 | mg / dL |
| Test | Age | Lower limit | Upper limit | Unit of measure | Therapeutic target |
| Plasma triglycerides | 10 - 39 years | 54 | 110 | mg / dL | <100 mg / dL or 1.1 mmol / L |
| 0.61 | 1.2 | mmol / L | |||
| 40 - 59 years | 70 | 150 | mg / dL | ||
| 0.77 | 1.7 | mmol / L | |||
| > 60 years | 80 | 150 | mg / dL | ||
| 0.9 | 1.7 | mmol / L | |||
| Plasma uric acid | 00:18 | 00:48 | mmol / L | ||
| Female | 2.0 | 7.0 | mg / dL | ||
| Male | 2.1 | 8.5 | mg / dL | ||
| Plasma creatinine | Male | 60 - 68 | 90 - 118 | mmol / L | |
| 0.7 - 0.8 | 1.0 - 1.3 | mg / dL | |||
| Female | 50 - 68 | 90 - 98 | mmol / L | ||
| 0.6 - 0.8 | 1.0 - 1.1 | mg / dL | |||
| Plasma alanine transaminase (ALT / ALAT) | 5 - 7 - 8 | 20 - 21 - 56 | U / L | ||
| Female | 00:15 | 0.75 | μ / L | ||
| Male | 00:15 | 1.1 | |||
| Plasma transaminase aspartate (AST / ASAT) | Female | 6 | 34 | IU / L | |
| 00:25 | 0.60 | μ / L | |||
| Male | 8 | 40 | IU / L | ||
| 00:25 | 0.75 | μ / L | |||
| Plasma alkaline phosphatase (ALP) | Female | 42 | 98 | U / L | |
| Male | 53 | 128 | |||
| (Enzymatic activity) | 0.6 | 1.8 | μ / L | ||
| Gamma glutamyl transferase plasma (GGT) | 5 - 8 | 40 - 78 | U / L | ||
| Female | 0.8 | μkat / L | |||
| Male | 1.3 | ||||
| Plasma creatine kinase (CK) | Male | 24 - 38 - 60 | 174 - 320 | U / L or ng / mL | |
| Female | 24 - 38 - 96 | 140 - 200 |
| Test | Lower normal limit | Upper limit of normal | Unit of measure |
| Total plasma proteins | 60 - 63 | 78 - 82 - 84 | g / L |
| Plasma albumin | 35 | 48 - 55 | g / L |
| 3.5 | 4.8 - 5.5 | U / L | |
| 540 | 740 | mmol / L | |
| Plasma globulin | 23 | 35 | g / L |
| Total plasma bilirubin | 1.7 - 2 - 3.4 - 5 | 17 - 22 - 25 | mmol / L |
| 0.1 - 0.2 - 0.29 | 1.0 - 1.3 - 1.4 | mg / dL |
| Test | Type of patient | Lower limit | Upper limit | Unit |
| TSH or plasma thyroid stimulating hormone | Adults - standard range | 0.3 - 0.4 - 0.5 - 0.6 | 4.0 - 4.5 - 6.0 | mIU / L or μIU / mL |
| Adults - optimal range | 0.3 - 0.5 | 2.0 - 3.0 | mIU / L or μIU / mL | |
| 1.3 | 19 | mIU / L or μIU / mL | ||
| Free plasma thyroxine | Normal adults | 0.7 - 0.8 | 1.4 - 1.5 | ng / dL |
| 9 - 10 - 12 | 18 - 23 | pmol / L | ||
| Infants 0 - 3 days | 2.0 | 5.0 | ng / dL | |
| 26 | 65 | pmol / L | ||
| Newborns 3 - 30 days | 0.9 | 2.2 | ng / dL | |
| 12 | 30 | pmol / L | ||
| Children / teenagers 31 days - 18 years | 0.8 | 2.0 | ng / dL | |
| 10 | 26 | pmol / L | ||
| Pregnancy | 0.5 | 1.0 | ng / dL | |
| 6.5 | 13 | pmol / L | ||
| Total plasma thyroxine | 60 | 140 - 160 | nmol / L | |
| 4 - 5.5 | 11 - 12.3 | mg / dL | ||
| Plasmatic free triiodothyronine | Normal adults | 0.2 | 0.5 | ng / dL |
| 3.1 | 7.7 | pmol / L | ||
| Children 2 - 16 years | 0.1 | 0.6 | ng / dL | |
| 1.5 | 9.2 | pmol / L | ||
| Total plasma triiodothyronine | 0.9 - 1.1 | 2.5 - 2.7 | nmol / L | |
| 60 - 75 | 175 - 181 | ng / dL | ||
| Thyroid hormone binding globulin (TBG) | 12 | 30 | mg / L | |
| Thyroglobulin (Tg) | 1.5 | 30 | pmol / L | |
| 1 | 20 | mg / L | ||
| Plasma testosterone | Male - overall | 8 - 10 | 27 - 35 | nmol / L |
| 230 - 300 | 780 - 1000 | ng / dL | ||
| Male <50 years | 10 | 45 | nmol / L | |
| 290 | 1300 | ng / dL | ||
| Male> 50 years | 6.2 | 26 | nmol / L | |
| 180 | 740 | ng / dL | ||
| Female | 0.7 | 2.8 - 3.0 | nmol / L | |
| 20 | 80 - 85 | ng / dL | ||
| 17 - Plasmatic hydroxyprogesterone | Male | 00:06 | 3.0 | mg / L |
| Female (Follicular phase) | 0.2 | 1.0 | mg / L | |
| Plasma FSH | prepubertal | <1 | 3 | IU / L |
| Adult male | 1 | 8 | ||
| Adult female (luteal and follicular phase) | 1 | 11 | ||
| Adult Female (Ovulation) | 6 95% (standard) | 26 95% PI) | ||
| 5 90% (used in diagram) | 15 (90% PI) | |||
| Female - postmenopausal | 30 | 118 | ||
| Plasma luteinizing hormone (LH) | Female - peak | 20 90% (used in diagram) | 75 (90% PI) | IU / L |
| Female - postmenopausal | 15 | 60 | ||
| Plasma estradiol | Adult male | 50 | 200 | pmol / L |
| 1.4 | 5.5 | ng / dL | ||
| Adult female (day 5) | 70 95% (standard) | 500 95% PI | pmol / L | |
| 110 90% (used in diagram) | 220 90% PI | |||
| 1.9 (95% PI) | 14 (95% PI) | ng / dL | ||
| 3.0 (90% PI) | 6.0 (90% PI) | |||
| Adult female (preovulatory peak) | 400 | 1500 | pmol / L | |
| 11 | 41 | ng / dL | ||
| Adult female (luteal phase) | 70 | 600 | pmol / L | |
| 1.9 | 16 | ng / dL | ||
| Adult female - free estradiol | 00:05 | 0.9 | ng / dL | |
| 1.7 | 33 | pmol / L | ||
| Female - postmenopausal | N / A | <130 | pmol / L | |
| N / A | <3.5 | ng / dL | ||
| Plasmatic progesterone | Female (ovulation) | 2.2 (90%) | 9 (90%) | nmol / L |
| 70 (90% PI) | 280 (90% PI) | ng / dL | ||
| Plasma Androstenedione | Adult male and female | 60 | 270 | ng / dL |
| Female - postmenopausal | <180 | |||
| prepubertal | <60 | |||
| Plasma ACTH | 4.4 | 18 - 22 | pmol / L | |
| 20 | 80 - 100 | pg / mL | ||
| Plasma cortisol | Nine hours | 140 | 700 | nmol / L |
| 5 | 25 | mg / dL | ||
| Midnight | 80 | 350 | nmol / L | |
| 2.9 | 13 | mg / dL | ||
| Plasma growth hormone (fasting) | 0 | 5 | ng / mL | |
| Growth hormone (after stimulation with arginine) | 7 | n / a | ng / mL | |
| Plasma priorolactin | Female | n / a | 20 | ng / mL or µg / L |
| Male | 15 | |||
| Plasma parathormone (PTH) | 10 - 17 | 65 - 70 | pg / mL | |
| 1.1 - 1.8 | 6.9 - 7.5 | pmol / L | ||
| 25 - plasmatic isloxicalciferol (vitamin D) | Standard reference values | 8 - 9 | 40 - 80 | ng / mL |
| 20 - 23 | 95 - 150 | nmol / L | ||
| 25 - plasmatic isloxicalciferol (vitamin D) | Therapeutic Targets | 30 - 40 | 65 - 100 | ng / mL |
| 85 - 100 | 120 - 160 | nmol / L |
| Test | Lower normal limit | Upper limit of normal | Unit of measure | Comments |
| Plasma alpha-fetoprotein (AFP) | 0 | 44 | ng / mL | |
| Human chorionic beta gonadotropin (bHCG) | n / a | 5 | IU / l or mU / ml | in Male and female not pregnant |
| Plasma-specific prostate antigen (PSA) | n / a | 2.5 - 4 | μg / L or ng / mL | Under 45 years of age - must be less than 2 - 5 μg / L |
| Plasma lactate dehydrogenase (LDH) | 50 | 150 | U / L | |
| 0.4 | 1.7 | mmol / L | ||
| Plasma LDH (enzyme activity) | 1.8 | 3.4 | μkat / L | <70 years of age |
| Plasma amylase | 25 - 30 - 53 | 110 - 120 - 123 - 125 - 190 | U / L | |
| 00:15 | 1.1 | μ / L | ||
| Plasma reactive protein (CRP) | n / a | 5 - 6 | mg / L | |
| 200 - 240 | nmol / L | |||
| D - plasmatic dimer | n / a | 500 | ng / mL | High in pregnant women |
| 0.5 | mg / L | |||
| Plasma lipase | 7 - 10 - 23 | 60 - 150 - 208 | U / L | |
| Plasma ACE | 23 | 57 | U / L | |
| Plasma acid phosphatase | 3.0 | ng / mL |
| Test | Type of patient | Default values | Unit of measure | Optimal values | ||
| Lower limit | Upper limit | Lower limit | Upper limit | |||
| Plasma vitamin A | 30 | 65 | mg / dL | |||
| Plasma Vitamin B9 (Folic acid / Folate) - Serum | Age> 1 year | 3.0 | 16 | ng / mL or μg / L | 5 | |
| 6.8 | 36 | nmol / l | 11 | |||
| Plasma vitamin B9 (Folic acid / Folate) | 200 | 600 | ng / mL or μg / L | |||
| 450 | 1400 | nmol / L | ||||
| Pregnancy | ng / mL or μg / L | 400 | ||||
| nmol / L | 900 | |||||
| Plasma vitamin B12 (Cobalamin) | 130 - 160 | 700 - 950 | ng / L | |||
| 100 - 120 | 520 - 700 | pmol / L | ||||
| Plasma vitamin C (Ascorbic acid) | 0.4 | 1.5 | mg / dL | 0.9 | ||
| 23 | 85 | mmol / L | 50 | |||
| 25 - hydroxycholecalciferol (plasma vitamin D) | 8 - 9 | 40 - 80 | ng / mL | 30 - 40 | 65 - 100 | |
| 20 - 23 | 95 - 150 | nmol / L | 85 - 100 | 120 - 160 | ||
| Vitamin E | mmol / L | 28 | ||||
| mg / dL | 1.2 | |||||
NOTE: the reference plasma concentrations may vary more or less significantly from laboratory to laboratory and based on the bibliographic data consulted.
Bibliography: reference range for blood test (wikipedia)
